Softwr

Healthcare · head to head

Ambra Health vs Woebot Health

Ambra Health logo

Ambra Health

Healthcare

Cloud medical image exchange and vendor neutral archive, now part of Intelerad

From
On request
Rated
-
Full reviewWebsite
Woebot Health logo

Woebot Health

Healthcare

Conversational CBT chatbot that withdrew from consumer distribution and now sells only to payers and providers

From
On request
Rated
-
Full reviewWebsite

The short version

  • Each has a real cost: Ambra Health intelerad now owns Ambra and ambrahealth.com redirects to Intelerad client support, so a buyer is committing to the Intelerad portfolio roadmap and should get written positioning on Ambra versus Intelerad own cloud PACS before signing.; Woebot Health the company withdrew its consumer app in June 2025 after concluding FDA marketing authorisation was not achievable at acceptable cost, which is a plain signal about both regulatory position and commercial durability.
  • They diverge on capability: Ambra Health covers Image exchange, Woebot Health covers Scripted CBT dialogue.
  • Prices and features above were last checked on 1 September 2026.

Where they differ

Only the attributes on which Ambra Health and Woebot Health actually diverge.

Attributes where Ambra Health and Woebot Health differ
AttributeAmbra HealthWoebot Health
PlatformsWeb, iOS, AndroidiOS, Android, Web

Identical on both: starting price (On request), pricing model (quote), free tier (No), user rating (Not yet rated), category (Healthcare).

What each one covers

Drawn from each product's published feature list. An absence here means we hold no record of it - not that the product lacks it.

Only in Ambra Health

  • Image exchange
  • Cloud VNA
  • Zero footprint viewer
  • Patient upload portal
  • Identity reconciliation
  • Clinical trials workflow
  • API and HL7 integration

Only in Woebot Health

  • Scripted CBT dialogue
  • Mood tracking
  • Crisis routing
  • Between-session support
  • Payer deployment
  • Provider copilot positioning
  • Research licensing
  • Population reporting

What people use each for

The jobs each tool is most often brought in to do.

Ambra Health

  • A trauma centre that receives transfers from regional hospitals and needs outside CT studies readable before the patient arrives, not after a disc is walked innot Woebot Health
  • An oncology programme collecting outside imaging for multidisciplinary tumour board review from dozens of referring practicesnot Woebot Health
  • A clinical research organisation routing de identified trial imaging from many sites to one central reading facilitynot Woebot Health
  • A health system trying to eliminate the CD import desk by giving patients and referring practices a direct upload portalnot Woebot Health

Woebot Health

  • A health plan wanting a low intensity behavioural health option for members on a waiting list for therapynot Ambra Health
  • A provider organisation offering structured between-session CBT practice to patients already in treatmentnot Ambra Health
  • A research group running a trial that needs a clinically scripted rather than generative conversational agent for safety reasonsnot Ambra Health
  • A payer targeting a specific population such as postpartum members where scripted CBT content already existsnot Ambra Health

Where each one falls short

Documented limitations, not opinions. Every one is a constraint you would hit in normal use.

Ambra Health

  • Intelerad now owns Ambra and ambrahealth.com redirects to Intelerad client support, so a buyer is committing to the Intelerad portfolio roadmap and should get written positioning on Ambra versus Intelerad own cloud PACS before signing.
  • Ambra is built for cross organisation exchange, not for high volume in department diagnostic reading, so a radiology group that expects it to replace a departmental PACS finds the reading ergonomics and hanging protocols thinner than a dedicated PACS client.
  • Pricing scales with study volume and stored capacity, so a health system that turns on patient upload broadly sees storage grow from low value outside studies it never intended to retain, and the renewal reflects that.
  • Identity reconciliation of studies arriving with foreign patient identifiers still needs human review at volume, and sites that budget for zero touch matching end up staffing an imaging records queue.
  • Adoption depends on referring practices actually using the portal, and the vendor cannot make that happen, so image exchange projects frequently stall at the outreach and change management step rather than at the technology.

Woebot Health

  • The company withdrew its consumer app in June 2025 after concluding FDA marketing authorisation was not achievable at acceptable cost, which is a plain signal about both regulatory position and commercial durability.
  • It is not an FDA cleared treatment for any indication, so it cannot be positioned to members as therapy and cannot substitute for a covered behavioural health benefit.
  • The scripted, non-generative design that makes it safe also makes it feel rigid next to current conversational AI, and engagement drops off quickly once users hit the edges of the script.
  • Published evidence is short-horizon symptom change in selected populations, mostly young adults, with little evidence of durable benefit or effect at whole-population scale.
  • With consumer distribution gone, the remaining business depends on a small number of payer and provider contracts, so a buyer should assume real vendor continuity risk over a multi-year term.

Pricing, plan by plan

Ambra Health

On request
  • Ambra Health$undefined/year
    • Priced by annual study volume and stored capacity
    • Exchange partner connections and upload portals scoped per deployment
    • Zero footprint viewer licensed with the platform

Woebot Health

On request
  • Woebot for payers and providers$undefined/year
    • Contracted per member per month or as a population licence
    • Sold to health plans and provider organisations, not to employers or individuals
    • No consumer purchase route since the app closed in June 2025

Which should you pick?

Choose Ambra Health if

  • You need image exchange.
  • You work on Web, iOS, Android.
  • You also want cloud vna.
Ambra Health review

Choose Woebot Health if

  • You need scripted cbt dialogue.
  • You work on iOS, Android, Web.
  • You also want mood tracking.
Woebot Health review

Questions people ask

Is Ambra Health or Woebot Health better?
Neither clearly leads. Ambra Health starts at On request and Woebot Health at On request, and user ratings are close enough to be indistinguishable. Choose on capability and platform support.
Which is cheaper, Ambra Health or Woebot Health?
Ambra Health starts at On request and Woebot Health at On request.
Does Ambra Health or Woebot Health run on more platforms?
Ambra Health runs on Web, iOS, Android. Woebot Health runs on iOS, Android, Web.
What is Ambra Health best used for?
Ambra Health is most often used for a trauma centre that receives transfers from regional hospitals and needs outside ct studies readable before the patient arrives, not after a disc is walked in, an oncology programme collecting outside imaging for multidisciplinary tumour board review from dozens of referring practices, a clinical research organisation routing de identified trial imaging from many sites to one central reading facility, a health system trying to eliminate the cd import desk by giving patients and referring practices a direct upload portal. Of those, a trauma centre that receives transfers from regional hospitals and needs outside ct studies readable before the patient arrives, not after a disc is walked in and an oncology programme collecting outside imaging for multidisciplinary tumour board review from dozens of referring practices are not what Woebot Health is typically brought in for.
What can Ambra Health do that Woebot Health cannot?
Ambra Health covers Image exchange, Cloud VNA, Zero footprint viewer, Patient upload portal. Woebot Health covers Scripted CBT dialogue, Mood tracking, Crisis routing, Between-session support.

Answered from the vendors’ own pages

Ambra Health: Is Ambra Health still sold under its own name?

Yes. Intelerad still markets Ambra Health as a named product line, but the standalone website redirects to Intelerad, and support and contracting run through Intelerad.

Woebot Health: Is Woebot still available?

Not to consumers. The consumer app closed in June 2025. The company continues to offer the product to payers, providers and researchers.

Ambra Health: Can Ambra replace our PACS?

For image exchange, archiving and clinical viewing, yes. For high volume diagnostic radiology reading it is generally deployed alongside a departmental PACS rather than instead of one.

Woebot Health: Is it FDA cleared?

No. It held Breakthrough Device designation but never obtained marketing authorisation, and the founder cited the cost of that pathway as the reason for closing the consumer app.

Ambra Health: Is pricing published?

No. It is quoted by annual study volume, stored capacity and the scope of exchange connections.

Woebot Health: Is it generative AI?

Historically no. The dialogue is clinician-written and rule-based, a deliberate safety choice that limits how naturally it converses.

Ambra Health: Does the viewer require software on referring physician machines?

No. The viewer is zero footprint HTML5, which is the main reason referring practices adopt it at all.

Woebot Health: What does the evidence show?

Randomised studies reported reduced depressive symptoms over short periods in selected populations, notably young adults. That is symptom change in a trial, not demonstrated population outcomes.

Share

Related pages

More on Ambra Health

More on Woebot Health

Keep looking

Other head to heads